Menopausal status and severe pathological conditions: is there a place for bone and neuroendocrine markers?
Introduction. Menopause involves skeletal losses, which may be accelerated by breast cancer and associated therapy, as aromatase inhibitors. Case presentation. A 67-year old Caucasian female underwent 2 years ago a right mastectomy for breast cancer (invasive ductal carcinoma of mucinous type; 85-9...
Main Authors: | Dan Nicolae PADURARU, Adina GHEMIGIAN, Adriana Elena NICA, Ana VALEA, Mara CARSOTE |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2016-12-01
|
Series: | Romanian Journal of Medical Practice |
Subjects: | |
Online Access: | https://rjmp.com.ro/articles/2016.4/RJMP_2016_4_Art-11.pdf |
Similar Items
-
Menopausal status and severe pathological conditions: is there a place for bone and neuroendocrine markers?
by: Dan Nicolae PADURARU, et al.
Published: (2016-12-01) -
Serotonin: beyond menopause
by: Mara Carsote, et al.
Published: (2016-09-01) -
Determinants of bone mineral density in post-menopause
by: Cristiane F. F. Silva, et al.
Published: (2016-02-01) -
The neuroendocrine markers assay and the glycemia profile in patients with neuroendocrine tumors under octreotide therapy: a 2 years study / Determinarea markerilor neuroendocrini şi a profilului glicemic la pacienţii cu tumori neuroendocrine în tratament cu octreotid
by: Poiană Cătălina, et al.
Published: (2014-09-01) -
Periodontitis and bone mineral density among pre and post menopausal women: A comparative study
by: Suresh Snophia, et al.
Published: (2010-01-01)